Vancomycin (VCM ), a methiciline-cefem resistant Staphylococcus aureus (MRSA)-specific antibiotic, was incorporated in a self-setting tetracalcium phosphate (TTCP)-dicalcium phosphate dihydrate (DCPD) apatite cement that hardened isothermally into a hydroxyapatite (HAP) phase with crystallinity simi
Self-setting, bioactive, and biodegradable TTCP-DCPD apatite cement
β Scribed by Hamanishi, Chiaki ;Kitamoto, Katsunori ;Ohura, Kouichirou ;Tanaka, Seisuke ;Doi, Yutaka
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 643 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0021-9304
No coin nor oath required. For personal study only.
β¦ Synopsis
Tetracalcium phospha te-dicalcium phosphate dihydrate selfsetting apatite cement mixed with low-crystallized seed hydroxyapatite is similar to the host bone in degree of crystallinity. The bonding strength of this cement with hydroxyapatitecoated titanium rods was twice that with noncoated titanium and four times that with stainless steel. Histologically, TTCP-DCPD apatite cement incorporated into the tibia of rabbits were degraded, absorbed, and replaced by the normal body trabeculae rapidly. The mechanical strength of the cement disk intercalated into a gap made in the rabbit tibiae increased to 73% of that of the normal tibia at 10 weeks concurrently with the decrease in bone mineral density of the disk toward that of the normal tibia, in which bony replacement of the disk was observed also histologically. These bioactive and biodegradative characters of this cement are due to the similarity of its degree of crystallinity to that of the host bone, and could expand its clinical applications.
π SIMILAR VOLUMES
## Abstract Apatite cement and collagen were combined by a mechanochemical method to create a new selfβsetting apatite/collagen composite cement, and menatetrenone (VK2) was loaded into a drugβdelivery system to test biocompatibility in rats. Powder Xβray diffraction analysis (XRD), scanning electr
A novel device containing cephalexin as a model drug using a self-setting bioactive cement based on CaO-Si0,-P,O, glass was investigated. The device consisted of 95 wt/wt% glass powders and 5 wt/wt% cephalexin powder hardened within 5 min after mixing with a phosphate buffer. After setting, in vitro
Resistance to compressive strength after setting of the calcium phosphate cement consisting of tetracalcium phosphate (TECP), dicalcium phosphate dihydrate (DCPD), and 40 wt/wt% of a synthetic hydroxyapatite (HAP) was tested. An equimolar mixture of the calcium phosphate powder containing DCPD (part
## Abstract In this study, a biphasic injectable bone substitute based on Ξ²βdicalcium silicate (Ca~2~SiO~4~) and plaster of Paris (CaSO~4~Β·1/2H~2~O) is presented, and its behavior as cement was studied and compared to that of pure Ca~2~SiO~4~ paste. The results demonstrated that the setting time of